tirzepatide redness at injection site Tirzepatide-Induced Reaction Injection Site Reactions with Tirzepatide:

It is supplied only for laboratory research use by qualified professionals under controlled environments.

Semaglutide demonstrated a consistent reduction in MACE and its components vs placebo, regardless of baseline CV risk profile

Emanuel, Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity

The label also warns about potential acute gallbladder disease and notes that tirzepatide may reduce the absorption of oral medications due to delayed gastric emptying, including oral contraceptives, which may require backup contraception for 4 weeks after initiation and after each dose increase